• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

Bortezomib manufacturer

Cirrhotic rats show higher expression levels of hepatic RhoA and Rho-kinase

May 27, 2019 by Katherine Lewis Leave a Comment

Cirrhotic rats show higher expression levels of hepatic RhoA and Rho-kinase than normal healthy rats, and the activation of this signaling pathway leads to portal hypertension. GGPP-treated rat main hepatic stellate cells (HSCs) and a human being stellate cell collection (LX-2) was examined by stream cytometry. Intrahepatic responsiveness and level of resistance to the 1-adrenoceptor … [Read more…]

Posted in: Blogging Tagged: Bortezomib manufacturer, Goat polyclonal to IgG H+L)

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by